Adele Baker

416 total citations
3 papers, 186 citations indexed

About

Adele Baker is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Adele Baker has authored 3 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Hematology and 1 paper in Oncology. Recurrent topics in Adele Baker's work include Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). Adele Baker is often cited by papers focused on Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). Adele Baker collaborates with scholars based in Australia, Netherlands and United States. Adele Baker's co-authors include Inge Verbrugge, Jake Shortt, Ricky W. Johnstone, Johannes Zuber, Lev M. Kats, Richard B. Lock, Eva Vidacs, Erwin M. Lee, Gareth P. Gregory and Jessica M. Salmon and has published in prestigious journals such as Blood and Cancer Research.

In The Last Decade

Adele Baker

3 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adele Baker Australia 3 155 87 60 19 12 3 186
Jean‐Richard Saint‐Martin United States 7 265 1.7× 122 1.4× 101 1.7× 18 0.9× 21 1.8× 25 300
Christopher D. Delaney United States 4 264 1.7× 82 0.9× 31 0.5× 10 0.5× 26 2.2× 6 298
Edward Ayoub United States 8 111 0.7× 97 1.1× 27 0.5× 31 1.6× 22 1.8× 27 175
Stefanie Kreutmair Germany 9 88 0.6× 53 0.6× 49 0.8× 13 0.7× 9 0.8× 21 173
Denice Hickman United States 6 121 0.8× 164 1.9× 68 1.1× 35 1.8× 26 2.2× 9 223
Kateřina Growková Czechia 6 136 0.9× 47 0.5× 51 0.8× 10 0.5× 9 0.8× 12 188
Devora Delman United States 6 91 0.6× 51 0.6× 72 1.2× 16 0.8× 23 1.9× 8 188
Elisha J. Dettman United States 7 124 0.8× 64 0.7× 61 1.0× 6 0.3× 13 1.1× 14 163
Ravi Vij United States 4 117 0.8× 137 1.6× 60 1.0× 5 0.3× 5 0.4× 13 171
Dixil Francis United States 4 197 1.3× 231 2.7× 100 1.7× 7 0.4× 7 0.6× 5 279

Countries citing papers authored by Adele Baker

Since Specialization
Citations

This map shows the geographic impact of Adele Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Baker more than expected).

Fields of papers citing papers by Adele Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Baker. The network helps show where Adele Baker may publish in the future.

Co-authorship network of co-authors of Adele Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Adele Baker. A scholar is included among the top collaborators of Adele Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele Baker. Adele Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Baker, Adele, Gareth P. Gregory, Inge Verbrugge, et al.. (2015). The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia. Cancer Research. 76(5). 1158–1169. 83 indexed citations
2.
Bots, Michael, Inge Verbrugge, Benjamin P. Martin, et al.. (2014). Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood. 123(9). 1341–1352. 99 indexed citations
3.
Hein, Nadine, Megan J. Bywater, Kim Stanley, et al.. (2011). Inhibition of RNA Polymerase I Transcription by CX-5461 As a Therapeutic Strategy for the Cancer-Specific Activation of p53 in MLL-Rearranged Acute Myeloid Leukemias. Blood. 118(21). 1548–1548. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Richard Saint‐Martin Breakdown of academic impact, for papers by Christopher D. Delaney Breakdown of academic impact, for papers by Edward Ayoub Breakdown of academic impact, for papers by Stefanie Kreutmair Breakdown of academic impact, for papers by Denice Hickman Breakdown of academic impact, for papers by Kateřina Growková Breakdown of academic impact, for papers by Devora Delman Breakdown of academic impact, for papers by Elisha J. Dettman Breakdown of academic impact, for papers by Ravi Vij Breakdown of academic impact, for papers by Dixil Francis
Rankless by CCL
2026